Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

University researchers receive cancer funding

Release issued 2nd May 2008

University researchers receive cancer funding


By Communications Staff
Friday, May 2, 2008

Two Western-based researchers are among 41 Ontario researchers to receive funding from the Canadian Cancer Society.

Robarts Research Institute scientist Paula Foster and Schulich School of Medicine & Dentistry’s David Litchfield will receive more than $885,000 to fund innovative research projects to understand how cancer cells spread through the body and why cancer cells continue to divide in an uncontrolled way that other cells do not.

Foster will study how cancer cells metastasize (spread to other parts of the body) through the body’s lymphatic system. Although lymph nodes can be surgically inspected to see if a cancer has spread, little is known about how cancer cells travel through these organs. Foster’s group will use high-tech imaging (MRI) and nanotechnology to study this process.

Litchfield will study how cancer cells communicate, prompting them to continue growing in the absence of normal cellular cues. Litchfield’s work may help find new targets for anti-cancer drugs.

“Right here in London ground-breaking cancer research is happening,” says Angie Woodcock, Manager, Elgin Middlesex Unit, Canadian Cancer Society. “Both of these outstanding researchers are based at The University of Western Ontario, so it is very exciting to see those dollars supporting the work of London researchers.”

The two newly funded projects at Western are in addition to seven projects currently being supported by the Canadian Cancer Society in London. These other projects, previously awarded, will receive a total of $730,000 for this fiscal year from the Cancer Society.

Over the past five years, researchers in the London area have been awarded more than $5.6 million in cancer research funding.

Company details

If you want to find out more about the company visit The University of Western Ontario - Industry Liaison profile.

Latest The University of Western Ontario - Industry Liaison press releases

Small trial ad
Bioiberica
Profile your company today
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us